SIREN BIOTECHNOLOGY Trademark

Trademark Overview

On Friday, July 29, 2022, a trademark application was filed for SIREN BIOTECHNOLOGY with the United States Patent and Trademark Office. The USPTO has given the SIREN BIOTECHNOLOGY trademark a serial number of 97525163. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, August 20, 2024. This trademark is owned by Siren Biotechnology, Inc.. The SIREN BIOTECHNOLOGY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Testing, inspection, research, or development of pharmaceutical preparations for gene therapy
siren biotechnology

General Information

Serial Number97525163
Word MarkSIREN BIOTECHNOLOGY
Filing DateFriday, July 29, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, August 20, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 27, 2023

Trademark Statements

NOT AVAILABLE"BIOTECHNOLOGY"
Goods and ServicesTesting, inspection, research, or development of pharmaceutical preparations for gene therapy

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, August 2, 2022
Primary Code042
First Use Anywhere DateWednesday, September 9, 2020
First Use In Commerce DateWednesday, May 17, 2023

Trademark Owner History

Party NameSiren Biotechnology, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94107
Party NameSiren Biotechnology, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94158

Trademark Events

Event DateEvent Description
Tuesday, August 2, 2022NEW APPLICATION ENTERED
Tuesday, August 2, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 15, 2023ASSIGNED TO EXAMINER
Monday, May 22, 2023EXAMINERS AMENDMENT -WRITTEN
Monday, May 22, 2023EXAMINERS AMENDMENT E-MAILED
Monday, May 22, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, May 22, 2023EXAMINER'S AMENDMENT ENTERED
Tuesday, June 27, 2023PUBLISHED FOR OPPOSITION
Monday, May 22, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 7, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 22, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 27, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, February 22, 2024SOU EXTENSION 1 FILED
Monday, March 25, 2024ABANDONMENT - NO USE STATEMENT FILED
Sunday, April 7, 2024USE AMENDMENT FILED
Monday, March 25, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Sunday, April 7, 2024NOTICE OF REVIVAL - E-MAILED
Sunday, April 7, 2024TEAS PETITION TO REVIVE RECEIVED
Sunday, April 7, 2024PETITION TO REVIVE-GRANTED
Sunday, April 7, 2024SOU EXTENSION RECEIVED WITH TEAS PETITION
Sunday, April 7, 2024TEAS STATEMENT OF USE RECEIVED
Sunday, April 7, 2024TEAS PETITION TO REVIVE RECEIVED
Monday, April 29, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, May 1, 2024SOU EXTENSION 1 GRANTED
Wednesday, May 1, 2024STATEMENT OF USE PROCESSING COMPLETE
Saturday, June 1, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 2, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 6, 2024NON-FINAL ACTION E-MAILED
Monday, May 6, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 6, 2024SU - NON-FINAL ACTION - WRITTEN
Tuesday, August 20, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, August 20, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Saturday, June 1, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, June 1, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Related Keywords

biotechnology siren preparations gene therapy pharmaceutical development inspection research testing